Nervgen Pharma NGEN
NASDAQ NGEN
$1.35 +0.02 (+1.50%)
At close: Nov 11, 2026 · 4:00 PM EST

Nervgen Pharma (NGEN) Total Non-Current Liabilities (2024 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Total Non-Current Liabilities of $3.02 million in Q2 2026, down 28.5% from the prior quarter.

Analysis

Nervgen Pharma (NGEN) Total Non-Current Liabilities (2024 - 2026) Analysis & Trends

At the end of FY2025, Nervgen Pharma reported Total Non-Current Liabilities of $1.64 million.

  • Across earlier years, Total Non-Current Liabilities came in at $5,832 in FY2024 (-92.7%) and $79,766 in FY2023.
  • Quarterly Total Non-Current Liabilities has ranged from $5,832 in Q4 2024 to $4.22 million in Q1 2026 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Nervgen Pharma 105.93 Mn 4.82 Mn - 3.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.02 Mn
Mar 31, 2026 4.22 Mn
Dec 31, 2025 1.64 Mn
Dec 31, 2024 5,832.14
Jan 1, 2024 79,766.15
API Access

Nervgen Pharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NGEN&period=max&api_key=YOUR_API_KEY